Please login to the form below

Not currently logged in
Email:
Password:

bacterial infections

This page shows the latest bacterial infections news and features for those working in and with pharma, biotech and healthcare.

Researchers discover new antibiotic using AI

Researchers discover new antibiotic using AI

There are approximately 25, 000 deaths in Europe alone each year resulting from drug-resistant bacterial infections, with the World Health Organization (WHO) identifying antimicrobial resistance as a global threat to

Latest news

More from news
Approximately 2 fully matching, plus 60 partially matching documents found.

Latest Intelligence

  • GSK forges ahead with its dynamic COPD and asthma portfolio GSK forges ahead with its dynamic COPD and asthma portfolio

    We’ve identified that about 60-70% of COPD exacerbations are related to infections, usually viral infections, which then trigger bacterial infections,” said Professor Barnes. ... There is a big challenge to find ways of preventing those infections.

  • The global antibiotic crisis: a 2020 perspective The global antibiotic crisis: a 2020 perspective

    saving AMR drugs sparingly to avoid widespread emergence of new drug-resistant infections. ... 2020. It seeks to incentivise drug developers by changing the way Medicare reimburses hospitals for treating patients with bacterial infections.

  • Tackling antimicrobial resistance on multiple fronts Tackling antimicrobial resistance on multiple fronts

    Vaccines to reduce bacterial infections are also urgently needed – although these are also not seen as lucrative enough to attract investment. ... The good news is that advanced technical work is ongoing around the world to develop new technology and

  • Combining therapies and combining research Combining therapies and combining research

    If we can’t defend ourselves from basic bacterial infections, we render other areas of medicine redundant. ... However, antibiotics for common bacterial infections, for example, staphylococci and Escherichia coli continued to be single molecule

  • Another lost decade for research? Another lost decade for research?

    Such technologies, which allow doctors to diagnose bacterial from viral infections or distinguish between different bacteria, could lead to personalised treatments and avoid unnecessary prescription of antibiotics. ... In terms of research focus, the

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

  • Nabriva Therapeutics appoints chief medical officer Nabriva Therapeutics appoints chief medical officer

    Jennifer Schranz will lead the company’s clinical development business. Nabriva Therapeutics, a biopharma focused on treating bacterial infections, has appointed a new chief medical officer in the form of Jennifer ... we continue to advance the

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Bacterial infections focussed Nabriva Therapeutics has appointed Francesco Maria Lavino as its chief commercial officer ahead of the group’s phase III clinical trial for lefamulin - a potential new treatment for ... I am looking forward to working with

  • Dr Engelbert Tjeenk Willink joins Allecra Therapeutics Dr Engelbert Tjeenk Willink joins Allecra Therapeutics

    He said: “Allecra is a dynamic company with the potential to make a significant impact on the growing and widespread epidemic of drug-resistant bacterial infections. ... Hooftman’s new role will see him focus on combating multi drug-resistant

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Antibiotic resistance: The silent pandemic

    Antibiotic resistance. Antibiotics are medicines used in the treatment and prevention of bacterial infections. ... Rather than relying on antibiotics to treat infections, we need to be more vigilant in primary prevention by:.

  • Diagnosing the lag in neuropsychiatric treatments

    bacterial – the therapy would not improve patient’s outcomes (Chandler, 2013). ... The answer is simple, while bacterial and viral infections could be distinguished through characteristic biomarkers, reliable biomarkers for psychiatric diseases are

  • Rare Disease Day 2018: Five things you should know about rare diseases.

    Rare diseases can be inherited (e.g. mucopolysaccharidoses [3]), or caused by bacterial or viral infections (e.g. ... 4. Genetic and Rare Diseases Information Center. Bacterial infections. Available at: .

  • Antibiotic Resistance: Alarm bells ring louder than ever

    in day-to-day use and routine medical procedures no longer being able to cure simple bacterial infections.  . ... First, bacterial infections tend to be short term, hence they are much less profitable than chronic illnesses where medication needs to be

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics